ArticleNeuroscience letters2023
Splenium tract projections of the corpus callosum to the parietal cortex classifies Alzheimer's disease and mild cognitive impairment.
Article in Neuroscience letters, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
4 citing papers in PubMed, 10 citations in OpenAlex.
- Unveiling genetic architecture of white matter microstructure through unsupervised deep representation learning of fractional anisotropy maps.Research square · 2025Article
- Distinguishing Early from Late Mild Cognitive Impairment Using Magnetic Resonance Free-Water Diffusion Tensor Imaging.NeuroSci · 2025Article
- Altitude-related features and prognosis in patients with reversible splenial lesion syndrome.Annals of medicine · 2024Article
- Automatic Detection of Cognitive Impairment in Patients With White Matter Hyperintensity Using Deep Learning and Radiomics.American journal of Alzheimer's disease and other dementiasArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors at 1 institution in 1 country.
Funding
Abstract
The corpus callosum (CC) is the largest bundle of white matter tracts in the brain connecting the left and right cerebral hemispheres. The posterior region of the CC, known as the splenium, seems to be relatively preserved throughout the lifespan and is regularly examined for indications of various pathologies, including Alzheimer's disease (AD) and Mild Cognitive Impairment (MCI). However, the splenium has rarely been investigated in terms of its distinct inter-hemispheric tract bundles that project to bilateral occipital, parietal and temporal areas of the cortex. The aim of the present study was to determine if any of these sub-splenium tract bundles are specifically affected by individuals with AD and MCI compared to normal controls. Diffusion Tensor Imaging was used to directly examine the integrity of these distinct tract bundles and their diffusion metrics were compared between groups of MCI, AD, and control individuals. Results revealed that differences between MCI, AD, and controls were particularly evident at parietal tracts of the CC splenium and were consistent with an interpretation of compromised white matter integrity. Combined parietal tract diffusivity and density information strongly discriminated between AD patients and controls with an accuracy (AUC) of 97.19%. Combined parietal tract diffusivity parameters correctly classified MCI subjects against controls with an accuracy of 74.97%. These findings demonstrated the potential of examining the CC splenium in terms of its distinct inter-hemispheric tract bundles for the diagnosis of AD and MCI.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.